These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 15146720)
1. Statin therapy: more than meets the eye? McCain J Manag Care; 2004 Apr; 13(4):40-9. PubMed ID: 15146720 [No Abstract] [Full Text] [Related]
2. Study stirs debate about statin use in those without high cholesterol. Mayo Clin Womens Healthsource; 2009 Apr; 13(4):3. PubMed ID: 19255535 [No Abstract] [Full Text] [Related]
3. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men. Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E; J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343 [TBL] [Abstract][Full Text] [Related]
12. Identifying patients for aggressive cholesterol lowering: the risk curve concept. Robinson JG; Stone NJ Am J Cardiol; 2006 Nov; 98(10):1405-8. PubMed ID: 17134640 [TBL] [Abstract][Full Text] [Related]
13. Compliance and refill pattern behavior with HMG-CoA reductase inhibitors after acute myocardial infarction. Coombs JH; Cornish L; Hiller P; Smith DG Manag Care Interface; 2002 Jan; 15(1):54-8, 60. PubMed ID: 11828605 [TBL] [Abstract][Full Text] [Related]
14. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia. Bays HE; Davidson M; Jones MR; Abby SL Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026 [TBL] [Abstract][Full Text] [Related]
15. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe. Daskalopoulou SS; Mikhailidis DP Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035 [TBL] [Abstract][Full Text] [Related]
16. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention? Mora S; Ridker PM Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935 [TBL] [Abstract][Full Text] [Related]
18. Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy. Lima JA; Desai MY; Steen H; Warren WP; Gautam S; Lai S Circulation; 2004 Oct; 110(16):2336-41. PubMed ID: 15477398 [TBL] [Abstract][Full Text] [Related]
19. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy. Pearson TA; Ballantyne CM; Veltri E; Shah A; Bird S; Lin J; Rosenberg E; Tershakovec AM Am J Cardiol; 2009 Feb; 103(3):369-74. PubMed ID: 19166691 [TBL] [Abstract][Full Text] [Related]